GSK outlook brightens as Brexit brings currency windfall
July 27, 2016 at 07:16 AM EDT
LONDON, July 27 (Reuters) - Demand for new medicines helped GlaxoSmithKline grow earnings in the second quarter and the drugmaker is set for big gains in the rest of 2016 thanks to a weak pound, after Britain's vote to leave the European Union.
